Tania H. Anegawa

Londrina, PR, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Corrigendum to 'Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors': [Research and Practice in Thrombosis and Haemostasis Volume 9, Issue 6, August 2025, 103006].

Corrigendum to 'Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors': [Research and Practice in Thrombosis and Haemostasis Volume 9, Issue 6, August 2025, 103006].

Journal: Research and practice in thrombosis and haemostasis

Published: February 18, 2026

Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors.

Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors.

Journal: Research and practice in thrombosis and haemostasis

Published: May 12, 2025

Genomic ancestry, F8 variants, and immune tolerance in hemophilia A patients with inhibitors: exome sequencing insights.

Genomic ancestry, F8 variants, and immune tolerance in hemophilia A patients with inhibitors: exome sequencing insights.

Journal: Haematologica

Published: December 20, 2024

Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors.

Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors.

Journal: Thrombosis research

Published: May 11, 2024

Time between inhibitor detection and start of immune tolerance induction: Association with outcome in the BrazIT study.

Time between inhibitor detection and start of immune tolerance induction: Association with outcome in the BrazIT study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 13, 2022

Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and Way Forward.

Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and Way Forward.

Journal: Cancers

Published: August 31, 2021

The recurrence of the melanotic neuroectodermal tumour of infancy: an unusual presentation of a rare tumour.

The recurrence of the melanotic neuroectodermal tumour of infancy: an unusual presentation of a rare tumour.

Journal: Ecancermedicalscience

Published: January 03, 2020

Penetrance of the TP53 R337H Mutation and Pediatric Adrenocortical Carcinoma Incidence Associated with Environmental Influences in a 12-Year Observational Cohort in Southern Brazil.

Penetrance of the TP53 R337H Mutation and Pediatric Adrenocortical Carcinoma Incidence Associated with Environmental Influences in a 12-Year Observational Cohort in Southern Brazil.

Journal: Cancers

Published: October 05, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026